Aprea Therapeutics, Inc.
APRE
$0.79
-$0.04-5.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.14% | 15.10% | 2.77% | 3.47% | -7.13% |
| Total Depreciation and Amortization | 1.39% | 0.47% | -3.14% | -1.37% | 20.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.69% | -7.00% | 40.77% | 6.41% | 50.38% |
| Change in Net Operating Assets | -173.53% | -368.51% | 11.96% | -19.73% | 145.53% |
| Cash from Operations | 4.50% | 9.30% | 4.88% | 2.48% | 6.03% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,600.17% | 19,943.65% | -68.73% | -93.90% | -96.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12,647.49% | -2,637.38% | 69.10% | 96.79% | 98.02% |
| Cash from Financing | 6,327.23% | 23,252.29% | -68.69% | -93.65% | -96.09% |
| Foreign Exchange rate Adjustments | -107.32% | 190.91% | 166.20% | -218.44% | 140.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 303.09% | 307.65% | -763.94% | -1,496.81% | -1,303.43% |